BioSpace News Archive

Heidelberg Pharma AG announced that it has secured a financing commitment from its main shareholder dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, Germany

Recipharm announces that it has this morning acquired 4,881,437 Consort Shares, representing 9.9 per cent. of the existing issued share capital of Consort Medical, at 1,010 pence per share and a further 118,563 Consort Shares, representing 0.2 per cent. of the existing issued share capital of Consort Medical at 1,000 pence per share.

Genentech announced positive topline results from its pivotal Part 2 of the FIREFISH study looking at risdiplam in infants aged 1-7 months with Type 1 SMA.

Coherus BioSciences, Inc. announced the Company has entered into a licensing agreement with Innovent Biologics, Co., Ltd.,, a leading biopharmaceutical company headquartered in China, to commercialize Innovent’s biosimilar candidate to Avastin® in the United States and Canada.

The drug, a checkpoint inhibitor, met the primary endpoint of improved progression-free survival at the planned interim analysis.

Simply staying organized will help you make sure you never miss a beat. Here are a few small steps that’ll make a big difference.

Pharma and life sciences companies strengthen their leadership and boards with this week’s appointments.

Let’s see why gender diversity in the workplace matters and look at a simple game plan for making it work in your work environment.

Bill Doyle, executive chairman of the board of directors for NovoCure, said 2019, which included the U.S. approval of the first treatment for mesothelioma in 15 years, was an incredible year “on all fronts” for the company.

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of p30 antigens and antibodies for ASFV detection.